China Widens Drug Industry Probe, Visits Belgium's UCB, Inc.

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Belgian drugmaker UCB has been visited by Chinese authorities as the country widens investigations into bribery by drugmakers, following allegations against Britain's GlaxoSmithKline. A spokesman for UCB said on Thursday that officials were also investigating other drug companies with operations in the country, although he did not identify them. A number of international firms - including Novartis, Roche, Johnson & Johnson and AstraZeneca - denied any knowledge of being investigated following the UCB news.

Help employers find you! Check out all the jobs and post your resume.

Back to news